Skip to main content
LFST logo

LFST · LifeStance Health Group, Inc. · Executive Compensation

Track LFST — free
$12.93 +0.37 (+2.95%) At close · Oct 23
Market Cap
$4.94B
Shares
382.06M
Volume · Oct 23 2.98M Avg daily vol (3M) 4.29M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Kenneth Burdick $7,122,028
David Bourdon $6,645,380
Ryan McGroarty $6,515,416
Pablo Pantaleoni $3,593,253
Ryan Pardo $2,576,460
Ann Varanakis $1,821,027
Vaughn Paunovich $1,780,604
Fiscal 2024
Executive Total
Danish Qureshi $12,393,164
Kenneth Burdick $10,204,676
David Bourdon $3,446,530
Pablo Pantaleoni $2,756,050
Ryan Pardo $2,612,360
Kevin Mullins $2,165,575
Ann Varanakis $1,670,492
Fiscal 2023
Executive Total
Kenneth Burdick $14,829,496
Danish Qureshi $3,738,662
David Bourdon $2,354,954
Pablo Pantaleoni $2,129,134
Ryan Pardo $1,945,838
Fiscal 2022
Executive Total
Kenneth Burdick $40,953,095
Danish Qureshi $13,958,707
Michael Lester $9,808,706
David Bourdon $4,992,543
Fiscal 2021
Executive Total
Michael Lester $147,001,804

Executive changes

Person Change Filed
Teresa DeLuca, M.D. Resigned 2026-10-16
Safwan Shabab Appointed 2026-07-07
Lori Goltermann Appointed 2026-07-07
Thurman Justice Appointed 2026-07-07
Jeffrey Rhodes Resigned 2026-07-07
Lisa Miller Appointed 2026-03-11
Kenneth Burdick Appointed 2026-02-25
Sarah Personette Appointed 2025-08-22
William Miller Resigned 2025-08-22
Vaughn Paunovich Appointed 2025-05-14
Ryan McGroarty Appointed 2025-02-27
David Bourdon Appointed 2025-02-27
David Bourdon Appointed 2025-02-27
Danish Qureshi Terminated 2024-07-03
Danish Qureshi Resigned 2024-05-09
Teresa DeLuca Appointed 2024-03-12
David Bourdon Appointed 2022-11-03
Michael Lester Retired 2022-09-08
Kenneth Burdick Appointed 2022-09-08
Michael Lester Retired 2022-09-08
Kenneth Burdick Appointed 2022-09-08

Leadership

Key facts CIK 1845257 CUSIP 53228F101 13F (30d) 52 filings 52 filers Visit website Investor relations